Annual EBITDA
-$41.09 M
-$4.37 M-11.89%
December 31, 2022
Summary
- As of February 10, 2025, NMTR annual EBITDA is -$41.09 million, with the most recent change of -$4.37 million (-11.89%) on December 31, 2022.
- During the last 3 years, NMTR annual EBITDA has fallen by -$15.89 million (-63.04%).
Performance
NMTR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$13.11 M
-$3.01 M-29.75%
March 31, 2023
Summary
- As of February 10, 2025, NMTR quarterly EBITDA is -$13.11 million, with the most recent change of -$3.01 million (-29.75%) on March 31, 2023.
- Over the past year, NMTR quarterly EBITDA has dropped by -$1.76 million (-15.55%).
Performance
NMTR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$42.86 M
-$1.76 M-4.29%
March 31, 2023
Summary
- As of February 10, 2025, NMTR TTM EBITDA is -$42.86 million, with the most recent change of -$1.76 million (-4.29%) on March 31, 2023.
- Over the past year, NMTR TTM EBITDA has dropped by -$166.60 thousand (-0.39%).
Performance
NMTR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NMTR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.9% | -15.6% | -0.4% |
| 3 y3 years | -63.0% | -333.6% | -76.9% |
| 5 y5 years | -268.1% | -16.1% | -70.0% |
NMTR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +11.9% | at low | +54.2% | at low | +16.7% | +6.3% |
| 5 y | 5-year | +63.0% | +39.8% | +333.6% | +232.3% | +76.9% | +48.7% |
| alltime | all time | +1121.1% | +39.8% | -5008.0% | +232.3% | +3600.8% | +48.7% |
9 Meters Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$13.11 M(+29.7%) | -$42.86 M(+4.3%) |
| Dec 2022 | -$41.09 M(+11.9%) | -$10.11 M(+18.8%) | -$41.09 M(+1.4%) |
| Sep 2022 | - | -$8.51 M(-23.6%) | -$40.53 M(-11.0%) |
| Jun 2022 | - | -$11.13 M(-2.0%) | -$45.57 M(+6.7%) |
| Mar 2022 | - | -$11.35 M(+18.8%) | -$42.69 M(+16.2%) |
| Dec 2021 | -$36.72 M(-36.1%) | -$9.55 M(-29.4%) | -$36.72 M(+15.5%) |
| Sep 2021 | - | -$13.54 M(+64.1%) | -$31.80 M(+30.0%) |
| Jun 2021 | - | -$8.25 M(+53.2%) | -$24.47 M(-59.1%) |
| Mar 2021 | - | -$5.39 M(+16.4%) | -$59.79 M(+4.1%) |
| Dec 2020 | -$57.43 M(+127.9%) | -$4.63 M(-25.5%) | -$57.43 M(-6.2%) |
| Sep 2020 | - | -$6.21 M(-85.8%) | -$61.21 M(-4.0%) |
| Jun 2020 | - | -$43.57 M(+1340.6%) | -$63.75 M(+163.2%) |
| Mar 2020 | - | -$3.02 M(-64.0%) | -$24.22 M(-3.9%) |
| Dec 2019 | -$25.20 M(+40.1%) | -$8.40 M(-3.9%) | -$25.20 M(+23.3%) |
| Sep 2019 | - | -$8.74 M(+115.8%) | -$20.44 M(+78.8%) |
| Jun 2019 | - | -$4.05 M(+1.2%) | -$11.43 M(+6.9%) |
| Mar 2019 | - | -$4.00 M(+9.7%) | -$10.70 M(-40.5%) |
| Dec 2018 | -$17.99 M | -$3.65 M(-1465.1%) | -$17.99 M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $267.20 K(-108.1%) | -$16.56 M(-13.6%) |
| Jun 2018 | - | -$3.31 M(-70.7%) | -$19.17 M(+3.4%) |
| Mar 2018 | - | -$11.30 M(+409.2%) | -$18.54 M(+66.1%) |
| Dec 2017 | -$11.16 M(+112.4%) | -$2.22 M(-5.2%) | -$11.16 M(+9.9%) |
| Sep 2017 | - | -$2.34 M(-13.0%) | -$10.16 M(+5.9%) |
| Jun 2017 | - | -$2.69 M(-31.3%) | -$9.59 M(+23.4%) |
| Mar 2017 | - | -$3.92 M(+223.0%) | -$7.77 M(+42.5%) |
| Dec 2016 | -$5.25 M(-28.1%) | -$1.21 M(-31.7%) | -$5.45 M(-16.5%) |
| Sep 2016 | - | -$1.77 M(+104.1%) | -$6.53 M(+6.6%) |
| Jun 2016 | - | -$869.00 K(-45.6%) | -$6.12 M(-3.0%) |
| Mar 2016 | - | -$1.60 M(-30.2%) | -$6.31 M(-13.6%) |
| Dec 2015 | -$7.30 M(-22.2%) | -$2.29 M(+66.7%) | -$7.30 M(-39.9%) |
| Sep 2015 | - | -$1.37 M(+29.7%) | -$12.15 M(+1.8%) |
| Jun 2015 | - | -$1.06 M(-59.2%) | -$11.93 M(+9.7%) |
| Mar 2015 | - | -$2.59 M(-63.7%) | -$10.88 M(+31.3%) |
| Dec 2014 | -$9.38 M(+178.8%) | -$7.13 M(+515.6%) | -$8.29 M(+615.6%) |
| Sep 2014 | - | -$1.16 M | -$1.16 M |
| Dec 2013 | -$3.37 M | - | - |
FAQ
- What is 9 Meters Biopharma annual EBITDA?
- What is the all time high annual EBITDA for 9 Meters Biopharma?
- What is 9 Meters Biopharma annual EBITDA year-on-year change?
- What is 9 Meters Biopharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for 9 Meters Biopharma?
- What is 9 Meters Biopharma quarterly EBITDA year-on-year change?
- What is 9 Meters Biopharma TTM EBITDA?
- What is the all time high TTM EBITDA for 9 Meters Biopharma?
- What is 9 Meters Biopharma TTM EBITDA year-on-year change?
What is 9 Meters Biopharma annual EBITDA?
The current annual EBITDA of NMTR is -$41.09 M
What is the all time high annual EBITDA for 9 Meters Biopharma?
9 Meters Biopharma all-time high annual EBITDA is -$3.37 M
What is 9 Meters Biopharma annual EBITDA year-on-year change?
Over the past year, NMTR annual EBITDA has changed by -$4.37 M (-11.89%)
What is 9 Meters Biopharma quarterly EBITDA?
The current quarterly EBITDA of NMTR is -$13.11 M
What is the all time high quarterly EBITDA for 9 Meters Biopharma?
9 Meters Biopharma all-time high quarterly EBITDA is $267.20 K
What is 9 Meters Biopharma quarterly EBITDA year-on-year change?
Over the past year, NMTR quarterly EBITDA has changed by -$1.76 M (-15.55%)
What is 9 Meters Biopharma TTM EBITDA?
The current TTM EBITDA of NMTR is -$42.86 M
What is the all time high TTM EBITDA for 9 Meters Biopharma?
9 Meters Biopharma all-time high TTM EBITDA is -$1.16 M
What is 9 Meters Biopharma TTM EBITDA year-on-year change?
Over the past year, NMTR TTM EBITDA has changed by -$166.60 K (-0.39%)